Skip to main content
ICPE 2023 Main banner
Final Program


ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Video

Massive Mabs

Sunday, August 27, 2023
1:30 PM – 3:00 PM ADT
Location:MR201

Presentations:

  • 1:30 PM – 1:45 PM ADT
    Longitudinal associations between body mass index and disease activity, and radiographic progression in rheumatoid arthritis patients receiving infliximab

    Presenting Author: Theresa Burkard, PhD (she/her/hers) – ETH Zurich

  • 1:45 PM – 2:00 PM ADT
    A pilot evaluation of switchback from biosimilars to originator-biologics in the Veterans Affairs population: a signal of biosimilar failure?

    Presenting Author: Kelly M. Bryan, PharmD (she/her/hers) – Veterans Affairs Center for Medication Safety, Department of Veterans Affairs

  • 2:00 PM – 2:15 PM ADT
    Decreased Discontinuation and Switching of b/tsDMARDs in RA When Treatment Aligns with Molecular Signature Response Classifier Results: An Analysis from The Study to Accelerate Information of Molecular Signatures (AIMS)

    Presenting Author: Jeffrey R. Curtis, MD, MS, MPH (he/him/his) – University of Alabama at Birmingham

  • 2:15 PM – 2:30 PM ADT
    Trends in Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among Commercially Insured Adults and Children in the United States, 2001-2020

    Presenting Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ

  • 2:30 PM – 2:45 PM ADT
    Integration of Immuno-oncology (IO) Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers: Analysis of the England National Cancer Registry

    Presenting Author: Hamid Mahmoudpour, PharmD, PhD (he/him/his) – Global Epidemiology, the healthcare business of Merck KGaA, Darmstadt, Germany

  • 2:45 PM – 3:00 PM ADT
    The use of denosumab and the risk of incidence of diabetes in patients with osteoporosis

    Presenting Author: Albert Tzu-Ming Chuang, PharmD – Institute of Clinical Pharmacy and Pharmaceutical Sciences (CPPS), College of Medicine, National Cheng Kung University, Tainan, Taiwan.